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**Page 324, Table 1,** which previously appeared as:Table 1Characteristics of opioids used for BTP (times in minutes)Analgesic onsetAvailabilityDwell timeOral morphine30--45′30NAOral oxycodone30--45′40--50NAOTFC15--305015FBT156515SLF10--15702FBSF15652--5INFS5--1080--90NAFPNS5--1070NA*BTP* breakthrough pain, *FBT* fentanyl buccal tablet, *FBSF* fentanyl buccal soluble film, *FBNS* fentanyl pectyn nasal spray, *INFS* intranasal fentanyl spray, *OTFC* oral transmucosal fentanyl cytrate, *SLF* sublingual fentanyl

Should appear as:Table 1Characteristics of opioids used for BTP (times in minutes)Analgesic onsetAvailabilityDwell timeOral morphine30--45′30NAOral oxycodone30--45′40--50NAOTFC15--305015FBT156515SLF10--15702FBSF15652--5INFS5--1080--90NAFPNS5--1070NAFCSL6\~70NA*BTP* breakthrough pain, *FBT* fentanyl buccal tablet, *FBSF* fentanyl buccal soluble film, *FBNS* fentanyl pectin nasal spray, *INFS* intranasal fentanyl spray, *OTFC* oral transmucosal fentanyl citrate, *SLF* sublingual fentanyl, *FCSL* fentanyl citrate sublingual

The online version of the original article can be found under doi:10.1007/s40265-015-0519-2.
